Form 4: Oncocyte Corp Director Andrew Arno Buys $99,998 Worth of Shares in Private Offering

Director Andrew Arno purchased 33,898 shares of Oncocyte Corp in a private offering at $2.95 per share.

Summary

• On April 11, 2024, Andrew Arno, a director of Oncocyte Corp, purchased 33,898 shares of common stock in a private offering.
• The purchase price was $2.95 per share, totaling approximately $99,998.
• Following the transaction, Arno directly owns 69,054 shares.
• Arno also indirectly owns 7,804 shares through JBA Investments LLC and 7,804 shares through MJA Investments LLC, where he serves as the Manager and has voting and disposal rights.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director buying shares suggests confidence, but it's a relatively small transaction.

Positives

• A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This transaction is a routine disclosure of insider trading activity. It is common for directors and officers of publicly traded companies to buy and sell shares of their company's stock. These transactions are closely monitored by regulators and investors for insights into management's view of the company's prospects.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholders as it signals confidence from a company director.

Key Dates